Trade

Zydus Wellness share price

Balanced risk
  • 40%Low risk
  • 40%Moderate risk
  • 40%Balanced risk
  • 40%High risk
  • 40%Extreme risk
  • 506.50(1.34%)
    April 21, 2026 15:44:50 PM IST
    • NSE
    • BSE
  • Vol : 4.22 M (NSE + BSE)
    Last 20 day avg : 5.25 M

Zydus Wellness is trading 1.34% upper at Rs 506.50 as compared to its last closing price. Zydus Wellness has been trading in the price range of 534.35 & 500.70. Zydus Wellness has given 9.87% in this year & 1.98% in the last 5 days. Zydus Wellness has TTM P/E ratio 70.18 as compared to the sector P/E of 22.35.There are 8 analysts who have initiated coverage on Zydus Wellness. There are 5 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -39.90 Crores in its last quarter.Listed peers of Zydus Wellness include Patanjali Foods (1.53%), Godrej Industries (1.47%), Britannia Industries (2.50%).The Mutual Fund holding in Zydus Wellness was at 18.43% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Zydus Wellness was at 3.17% in 31 Mar 2026. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 21, 2026, 07:34 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.48
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.03
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.24
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    19.54
    Indicates overvaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
500.70
Highest
534.35
52 week range
Lowest
321.24
Highest
552.40
Zydus Wellness Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Patanjali Foods
Moderately Bearish
467.501.5350,868.8745.225.230.440.05
Godrej Industries
Neutral
933.001.4731,384.6433.963.33-189.92
Britannia Industries
Neutral
5,844.002.501,40,905.5366.1333.351.2416.81
Nestle India
Bullish
1,378.707.092,65,856.7078.7260.571.049.08
Tata Consumer Products
Bullish
1,144.002.261,13,439.1083.935.830.703.32
Mutual Fund Ownership
View all
Quant Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 22.18
  • % of AUM 8.09
Quant ESG Equity Fund Regular Growth
4/5
  • Amount Invested (Cr.) 22.62
  • % of AUM 7.57
Quant Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 25.02
  • % of AUM 6.00
Quant Manufacturing Fund Regular Growth
NA
  • Amount Invested (Cr.) 48.74
  • % of AUM 5.61
Bajaj Finserv Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 13.60
  • % of AUM 2.38
Zydus Wellness Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-03Quarterly Results
2025-11-05Quarterly Results
2025-07-30Quarterly Results
2025-05-19Audited Results, Dividend & Stock Split
2025-02-04Quarterly Results
About the company Zydus Wellness
  • IndustryFood Processing
  • ISININE768C01028
  • BSE Code531335
  • NSE CodeZYDUSWELL
Zydus Wellness Limited operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The Company’s product portfolio includes brands with functional benefits, like Glucon-D, Complan, Sugar Free, Nycil, Everyuth and Nutralite. Glucon-D is a glucose powder brand. Glucon-D is available in regular and flavors of Tangy Orange & Nimbu Pani. Complan is a nutritional drink designed for growing school children and contains 34 vital nutrients along with 100% milk protein to support growth. Sugar Free is a low-calorie sweetener. Nycil is a prickly heat and cooling powder brand. It offers a range of skin care products under the brand name of Everyuth Naturals. It has four manufacturing facilities across three locations - Aligarh, Ahmedabad and Sikkim. It also has 18 co-manufacturing facilities in India, the United Arab Emirates (UAE), and New Zealand.
  • Management Info
  • Tarun AroraChief Executive Officer, Whole Time Director
  • Umesh ParikhChief Financial Officer
  • Nandish JoshiCompany Secretary, Compliance Officer
Zydus Wellness Share Price FAQs

Zydus Wellness is trading at 506.50 as on Tue Apr 21 2026 10:14:50. This is 1.34% upper as compared to its previous closing price of 499.80.

The market capitalization of Zydus Wellness is 16155.24 Cr as on Tue Apr 21 2026 10:14:50.

The average broker rating on Zydus Wellness is Strong Buy. The breakup of analyst rating is given below -

  • 5 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Zydus Wellness is 552.40 whereas the 52 wk low is 321.24

Zydus Wellness can be analyzed on the following key metrics -

  • TTM P/E: 70.18
  • Sector P/E: 22.35
  • Dividend Yield: 0.24%
  • D/E ratio: -

Zydus Wellness reported a net profit of 346.90 Cr in 2025.

The Mutual Fund Shareholding was 18.43% at the end of 31 Mar 2026.